On the mechanism of the inhibition of glutamine synthetase and creatine phosphokinase by methionine sulfoxide

Journal of Neuroscience Research

Volumn 43, Issue 1, 1996, Pages 107-111

  Zendedel Haghighi, A ^a,b   Maples, K R ^a  

^a EVOTEC AG   (Germany)

^b MAST Immunosystems   (United States)

Author keywords

creatine phosphokinase; glutamine synthetase; inhibition; methionine sulfoxide; oxidation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ASCORBIC ACID; CATALASE; CREATINE KINASE; GLUTAMATE AMMONIA LIGASE; METHIONINE SULFOXIDE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PRIORITY JOURNAL; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CATALASE; CATTLE; CREATINE KINASE; ENZYME INHIBITORS; FREE RADICALS; GLUTAMATE-AMMONIA LIGASE; METHIONINE; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PROTEIN DENATURATION; SERUM ALBUMIN, BOVINE; SHEEP; SUPEROXIDE DISMUTASE;

EID: 9044234774     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.490430114     Document Type: Article

References (14)

1. Carney JM, Starke-Reed PE, Oliver CN, Landum RW, Cheng MS, Wu JF, Floyd RA (1991): Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone. Proc Natl Acad Sci USA 88:3633-3636.
2. Floyd RA, Carney JM (1992): Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol S32:S22-S27.
3. Geddes JW, Anderson KJ, Cotman CW (1986): Senile plaques as aberrant sprout-stimulating structures. Exp Neurol 94:767-776.
4. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA (1994): A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc Natl Acad Sci USA 91:3270-3274.
5. Levine RL (1983): Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue. J Biol Chem 258:11823-11827.
6. Liang JJ, Gu CL, Kacher ML, Foote CS (1983): Chemistry of singlet oxygen (45): mechanisms of the photooxidation of sulfides. J Am Chem Soc 105:4717-4721.
7. 2+ homeostasis in Alzheimer's disease. Trends Neurosci 16:409-414.
8. Mattson MP, Tomaselli KJ, Rydel RE (1993b): Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 621:35-49.
9. Miller RE, Hackenberg R, Gershman H (1978): Regulation of glutamine synthetase in cultured 3T3-L1 cells by insulin, hydrocortisone, and dibutyryl cAMP. Proc Natl Acad Sci USA 75:1418-1422.
10. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993): Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687.
11. Rowe WB, Ronzio RA, Meister A (1969): Inhibition of glutamine synthetase by methionine sulfoximine. Studies on methionine sulfoximine phosphate. Biochemistry 8:2674-2680.
12. Selkoe DJ (1991): The molecular pathology of Alzheimer's disease. Neuron 6:487-498.
13. Tanzi RE, St. George-Hyslop PH, Gusella JF (1989): Molecular genetic approaches to Alzheimer's disease. Trends Neurosci 12:152-158.
14. Yanker BA, Duffy LK, Kirschner DA (1990): Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250:279-282.